Stimulation of accumbal GABAB receptors inhibits delta1- and delta2-opioid receptor-mediated dopamine efflux in the nucleus accumbens of freely moving rats

Eur J Pharmacol. 2018 Oct 15:837:88-95. doi: 10.1016/j.ejphar.2018.08.003. Epub 2018 Aug 5.

Abstract

The nucleus accumbens contains delta-opioid receptors that may decrease inhibitory neurotransmission. As GABAB receptors inhibit dopamine release, decrease in activation of GABAB receptors may be a mediator of delta-opioid receptor-induced accumbal dopamine efflux. If so, accumbal dopamine efflux induced by delta-opioid receptor activation should be suppressed by stimulating GABAB receptors. As delta-opioid receptors are further subdivided into delta1- and delta2-opioid receptors, we analysed the effects of the GABAB receptor agonist baclofen on delta1- and delta2-opioid receptor-mediated accumbal dopamine efflux in freely moving rats using in vivo microdialysis. Drugs were applied intracerebrally through the dialysis probe. Doses of compounds show total amount administered (mol) during 25-50 min infusions. Baclofen (2.5 and 5.0 nmol), which did not alter basal dopamine levels, inhibited the delta1-opioid receptor agonist DPDPE (5.0 nmol)-induced dopamine efflux. Baclofen (2.5 and 5.0 nmol) also inhibited the delta2-opioid receptor agonist deltorphin II (25.0 nmol)-induced dopamine efflux. A low dose of the GABAB receptor antagonist 2-hydroxysaclofen (100.0 pmol), which failed to alter basal accumbal dopamine levels, counteracted the inhibitory effects of baclofen (5.0 nmol) on DPDPE (5.0 nmol)- and deltorphin II (25.0 nmol)-induced dopamine efflux. The present results show that reduction in accumbal GABAB receptor-mediated inhibition of accumbal dopaminergic activity facilitates activation of delta1- and delta2-opioid receptor-induced increases in accumbal dopamine efflux. This study suggests that activation of delta1- and delta2-opioid receptors on the cell bodies and/or terminals of accumbal GABAergic interneurons inhibits GABA release and, accordingly, decreases GABAB receptor-mediated inhibition of dopaminergic terminals, resulting in enhanced accumbal dopamine efflux.

Keywords: Delta1-opioid receptor; Delta2-opioid receptor; Dopamine; GABA(B) receptor; Microdialysis; Nucleus accumbens.

MeSH terms

  • Animals
  • Baclofen / pharmacology
  • Dopamine / metabolism*
  • Enkephalin, D-Penicillamine (2,5)- / pharmacology
  • Male
  • Nucleus Accumbens / metabolism*
  • Oligopeptides / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / physiology
  • Receptors, GABA-B / physiology*
  • Receptors, Opioid, delta / physiology*

Substances

  • Oligopeptides
  • Receptors, GABA-A
  • Receptors, GABA-B
  • Receptors, Opioid, delta
  • deltorphin II, Ala(2)-
  • Enkephalin, D-Penicillamine (2,5)-
  • Baclofen
  • Dopamine